tirzepatide mechanism vs semaglutide vs. Semaglutide: A Comprehensive Comparison for Weight Loss Success Tirzepatide vs Semaglutide: A Comprehensive

Rawson, R

Slowed Gastric Emptying These medications decrease the speed at which food travels from the stomach to the intestine, prolonging fullness and curbing post-meal blood sugar spikes

Tirzepatide (Mounjaro for type 2 diabetes, Zepbound for weight management) is a dual GIP/GLP-1 receptor agonist that has generated questions about potential effects on sexual function

Our weight loss patients are treated to guidance and support at every stage

Relevant for clinical practice, our findings show that treatment with semaglutide lowered the risk of MACE compared to sitagliptin, while tirzepatide showed at least comparable benefit to dulaglutide, an older GLP-1 receptor agonist with established cardiovascular efficacy

This approach offers several advantages over traditional surgery: The risk of infection and other complications is significantly lower with minimally invasive procedures